Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercializing and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Lives Through Nuclear Medicine on a global scale.
Location: United States, Florida, Orlando
Employees: 501-1000
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Parthenon ... | parthenonc... |
Mentions in press and media 6
| Date | Title | Description |
| 27.06.2023 | ASP Isotopes Inc. Secures $9 Million Supply Contract with US Customer for Highly Enriched Isotopes | - |
| 27.06.2023 | ASP Isotopes Inc. Secures $9 Million Supply Contract with US Customer for Highly Enriched Isotopes | Approximately $900,000 to be Recorded in 3Q23, with Deliveries Anticipated to Begin in Q1 of 2024. /EIN News/ -- BOCA RATON, Fla., June 27, 2023 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” the “Company”), an advanced ma... |
| 22.02.2011 | 2010 Year-End Review | We had a strong finish to 2010 with high activity levels in regards to both the portfolio and new platform opportunities. We were also relieved for the return of more normal and healthier financial markets after two years of severe dislocat... |
| 01.06.2010 | Triad Isotopes Closes Acquisition of Covidien’s U.S. Network of Mallinckrodt Radiopharmacies | ORLANDO, FL—Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, announced today that it closed the previously announced acquisition of the U.S. radiopharmacy network owned and operated by Covidien, a leading global heal... |
| 17.12.2009 | Triad Isotopes Announces Agreement to Acquire Network of Covidien’s Mallinckrodt Radiopharmacies | Orlando, Florida – Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, today announced that it has entered into an agreement to acquire the U.S. radiopharmacy network currently owned and operated by Covidien, a leading ... |
| 17.12.2009 | Covidien to ditch U.S. radiopharmacies | Covidien (NYSE:COV) agreed to sell its 37 radiopharmacies in the U.S. to Triad Isotopes Inc. of Orlando, Fla., for an undisclosed amount. The Mansfield, Mass.-based medical products conglomerate said it’s making the move after examining the... |